|Dr. Randal D. Chase Ph.D.||Pres, CEO & Director||N/A||N/A||67|
|Dr. Alexander Krantz Ph.D.||Founder, COO, Chief Scientific Officer, VP of Research & Director||175k||N/A||76|
|Mr. Kenneth Clifford Philippe B.Comm, CA, CPA||Chief Financial Officer||14.36k||N/A||65|
Advanced Proteome Therapeutics Corporation, through its subsidiary Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. It develops patent-pending technology that combines anti-cancer therapies in a single agent to directly target cancer tumors. The company has a strategic relationship collaboration with the National Research Council of Canada to develop antibody-drug conjugates. Advanced Proteome Therapeutics Corporation is headquartered in Boston, Massachusetts.
Advanced Proteome Therapeutics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.